A reasonable chance it could cause serious harm or death.
Temperature Abuse; temperature excursion during shipping
| Distributed by / for | Sandoz Inc., Princeton, NJ 08540 |
| NDC | 00781-3246-02 |
| Full product label | Enoxaparin Sodium Injection, USP, 40 mg/0.4 mL, Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Rx Only; 0.4 mL Syringes, Manufactured for Sandoz Inc., Princeton, NJ 08540, NDC 00781-3246-02; Carton (10 x 0.4 mL Syringes), Manufactured by Shenzhen Techdow Pharmaceutical Co., Ltd. Shenzhen City, Guangdong Province 518057, China for Sandoz Inc., Princeton, NJ 08540, NDC 00781-3246-64 |
| Recalling firm | Sandoz Inc |
| Distribution | Nationwide in the US |
| Quantity | 45,036 cartons |
| Recall initiated | 2021-11-17 |
| Report date | 2021-12-08 |
| Recall completed | — |
| Recall number | D-0286-2022 |
| Classification | Class I |
| FDA status | Completed |
| Origin on file | Princeton NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗